Addressing Obesity During Psoriasis Patient Consultations - Report - MDSpire

Addressing Obesity During Psoriasis Patient Consultations

  • By

  • Joana Nicolau

  • Anna López-Ferrer

  • Pablo de la Cueva

  • February 2, 2026

  • 0 min

Share

Clinical Report: Addressing Obesity During Psoriasis Patient Consultations

Overview

Obesity is prevalent in up to 50% of psoriasis patients, impacting disease severity and treatment outcomes. This report evaluates obesity management strategies, including GLP-1 receptor agonists and bariatric surgery, highlighting their potential benefits in psoriasis care.

Background

The association between psoriasis and obesity is significant, with obesity exacerbating psoriasis severity and complicating treatment. Despite the lack of specific guidelines for managing obesity in psoriasis patients, addressing this comorbidity is crucial for improving overall health outcomes. A comprehensive approach that includes obesity management is essential for optimizing dermatological and cardiovascular health in these patients.

Data Highlights

GLP-1 receptor agonists (liraglutide, semaglutide) and tirzepatide have shown significant weight loss and improved metabolic health in psoriasis patients, with some studies indicating reduced psoriasis severity independent of weight loss.

Key Findings

  • Up to 50% of psoriasis patients are obese, increasing cardiovascular risk and disease severity.
  • Obesity is associated with poorer responses to biologic therapies in psoriasis patients.
  • GLP-1 receptor agonists can lead to weight loss and improved psoriasis outcomes.
  • A multidisciplinary approach is necessary for effective management of psoriasis and obesity.
  • Current guidelines do not specifically address obesity management in psoriasis, highlighting a gap in care.

Clinical Implications

Healthcare providers should incorporate obesity management strategies into the treatment plans for psoriasis patients to enhance treatment efficacy and reduce comorbidities. Regular screening for obesity and related complications should be a standard part of psoriasis care.

Conclusion

Addressing obesity in psoriasis patients is critical for improving treatment outcomes and overall health. A structured approach to obesity management should be integrated into psoriasis care protocols.

References

  1. The New Gastroenterologist, Source, 2025 -- Strategies for Managing Weight in Gastroenterology Practice
  2. Optometric Management, Source, 2012 -- Nutrition
  3. The New Gastroenterologist, Source, 2025 -- The Advancements in Obesity Treatment Approaches
  4. The Journal of Clinical Endocrinology & Metabolism, Source -- Should Obesity Classification Shift from Body Mass Index to Body Composition Metrics?
  5. Nature Reviews Rheumatology, Source -- The obesity–inflammation axis in psoriatic disease: mechanisms and therapeutic strategies
  6. Obesity Medicine Association, Source -- Obesity Algorithm
  7. PubMed, Source -- Impact of weight-loss interventions on psoriasis severity: A systematic review and meta-analysis
  8. The obesity–inflammation axis in psoriatic disease: mechanisms and therapeutic strategies | Nature Reviews Rheumatology
  9. Obesity Algorithm | Obesity Medicine Association
  10. Impact of weight-loss interventions on psoriasis severity: A systematic review and meta-analysis - PubMed

Original Source(s)

Related Content